Selected article for: "epithelial cell and immune activation"

Author: Tristan de Jong; Victor Guryev; Yury M. Moshkin
Title: Discovery of pharmaceutically-targetable pathways and prediction of survivorship for pneumonia and sepsis patients from the view point of ensemble gene noise
  • Document date: 2020_4_11
  • ID: f5w05rc2_22
    Snippet: Second, high ranking gene ensembles (pathways) could be immediately associated with host response to infection and, thus, pathology of the sepsis. These include legionellosis (a pathway responsible for atypical pneumonia caused by Legionella bacteria), epithelial cell signalling in Helicobacter pylori infection and leishmaniasis, and imbalances in these pathways either caused by corresponding infections or immune activation could lead to the seps.....
    Document: Second, high ranking gene ensembles (pathways) could be immediately associated with host response to infection and, thus, pathology of the sepsis. These include legionellosis (a pathway responsible for atypical pneumonia caused by Legionella bacteria), epithelial cell signalling in Helicobacter pylori infection and leishmaniasis, and imbalances in these pathways either caused by corresponding infections or immune activation could lead to the sepsis [38] [39] [40] . To that, ensemble gene noise in immune pathways, such as rheumatoid arthritis and primary immunodeficiency, contribute to the prediction of clinical outcome in sepsis patients ( Figure 3D , 5D and Table S3 ). Thus, we conclude that the ensemble gene noise uncovers novel approaches and insights to the discovery of biomarkers, prediction of clinical outcome and to the molecular mechanisms of a pathology from the point of view of imbalances in stoichiometry and gene noise of expression in gene ensembles.

    Search related documents:
    Co phrase search for related documents
    • clinical outcome and epithelial cell: 1, 2, 3
    • clinical outcome and gene ensemble: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical outcome and gene ensemble expression: 1, 2, 3
    • clinical outcome and gene noise: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical outcome and gene noise stoichiometry: 1
    • clinical outcome and host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • clinical outcome and immune activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • clinical outcome and immune pathway: 1, 2
    • clinical outcome and infection host response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical outcome and Legionella bacteria: 1
    • clinical outcome and novel approach: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical outcome and primary immunodeficiency: 1, 2
    • clinical outcome and rheumatoid arthritis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical outcome and sepsis pathology: 1, 2
    • clinical outcome and sepsis patient: 1, 2, 3
    • clinical outcome prediction and ensemble gene: 1, 2, 3, 4, 5
    • clinical outcome prediction and gene ensemble: 1, 2, 3, 4, 5
    • clinical outcome prediction and gene ensemble expression: 1, 2
    • clinical outcome prediction and gene noise: 1, 2, 3, 4, 5